-
Mashup Score: 4Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC - 1 month(s) ago
Several professional societies have developed evidence-based guidelines on the use of certain biomarkers to help determine which patients with non–small cell lung carcinoma (NSCLC) may benefit from im…
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet
Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC https://t.co/8UozXYwk0b #LCSM #lungcancer #oncology #immunotherapy #biomarkers @IASLC @Pathologists @PulmPathSoc @AMPath @LUNGevity